Veraxa Biotech (VRXA) director Warren Hosseinion discloses 700,000-share stake on Form 3
Rhea-AI Filing Summary
Veraxa Biotech Holding AG director Warren Hosseinion has filed an initial Form 3 reporting holdings in the company. The filing shows direct ownership of 700,000 Ordinary Shares as of June 9, 2026. This is a baseline disclosure of existing ownership rather than a new buy or sell transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hosseinion Warren
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 700,000 shares (Direct)
Footnotes (1)
Key Figures
Ordinary Shares held: 700,000 shares
1 metrics
Ordinary Shares held
700,000 shares
Direct ownership as of June 9, 2026
Key Terms
Form 3, Ordinary Shares, beneficial ownership
3 terms
Form 3 regulatory
"has filed an initial Form 3 reporting holdings in the company"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"This is an initial ownership statement, establishing his reported stake"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Veraxa Biotech (VRXA) Form 3 filing show for Warren Hosseinion?
The Form 3 filing shows that director Warren Hosseinion directly holds 700,000 Ordinary Shares of Veraxa Biotech Holding AG. This is an initial ownership statement, establishing his reported stake as of June 9, 2026, without indicating a recent trade.
Is Warren Hosseinion a director or officer in Veraxa Biotech (VRXA) according to the Form 3?
According to the Form 3, Warren Hosseinion is a director of Veraxa Biotech Holding AG and not listed as an officer. The filing identifies his role, then details his direct ownership of 700,000 Ordinary Shares as of June 9, 2026.
Does the Veraxa Biotech (VRXA) Form 3 include any derivative securities for Warren Hosseinion?
The Form 3 does not list any derivative securities for Warren Hosseinion. The derivative section is empty, and the only reported holding is 700,000 Ordinary Shares, making this a straightforward disclosure of common equity ownership as of June 9, 2026.